IP Library Assignment 042821/0512
Patent Assignment
Reel/Frame 042821/0512

Assignment of Assignor's Interest

Recorded: 2017-06-27 Pages: 5
Assignors
LYSSIKATOS, JOSEPH P.
Executed: 2006-11-14
MARMSATER, FREDRIK
Executed: 2006-11-14
ZHAO, QIAN
Executed: 2006-11-14
GRESCHUK, JULIE MARIE
Executed: 2006-11-14
Assignee
ARRAY BIOPHARMA, INC.
3200 WALNUT STREET, BOULDER, COLORADO, 80301
Covered Properties (2)
N4-Phenyl-Quinazoline-4-Amine Derivatives and Related Compounds as Erbb Type I Receptor Tyrosine Kinase Inhibitors for the Treatment of Hyperproliferative Diseases
Application: 15/599,867 →
Publication: US 2017/0252317
N4-Phenyl-Quinazoline-4-Amine Derivatives and Related Compounds as Erbb Type I Receptor Tyrosine Kinase Inhibitors for the Treatment of Hyperproliferative Diseases
Patent: 9,693,989 →
Application: 14/034,361 →
Publication: US 2014/0023643
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 27, 2017
From: LYSSIKATOS, JOSEPH P.; GRESCHUK, JULIE MARIE; HENNINGS, D. DAVID; LIU, WEIDONG
To: ARRAY BIOPHARMA, INC.
Reel/Frame 042821/0566 →